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Abstract. It has been suggested that detection of high risk 
human papillomavirus (HPV) in low grade cervical 
intraepithelial neoplasia contributes to transition to high grade 
lesions and cancer. Currently, the PAP smear is the primary 
screening tool to identify women with cervical disease, 
specifically cervical intraepithelial neoplasia (CIN). In the 
present study we examined the utility of HPV detection and 
typing by PCR, in women with cytological and/or histological 
evidence of low grade squamous lesion (LGSL), using stained 
PAP cervical smears. HPV infection was confirmed in 21 out 
of the 31 (68%) specimens examined. 
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helping to decide whether a patient with a mild abnormality 
needs immediate referral for colposcopy (9) providing a quality 
assurance in cervical cytopathology (12). 
Although the detection of HPV infections using colposcopy, 
histology and cytology has been claimed, these techniques are 
not able to identify the virus itself, but detect the (sub-) clinical 
manifestation of the HPV infection (13). Moreover, the 
formation of koilocytes, the main cytological and histological 
criterion for HPV infection, and HPV-specific colposcopie 
pattern, can also be caused by agents other than HPV, while 
koilocytes can be absent in HPV infections (14). Thus the 
sensitivity and specificity of each of these techniques in HPV 
detection are rather low and controversial (15). Furthermore, 
they fail to discriminate between the different types of HPV 
(16). 
With the use of the polymerase chain reaction (PCR) 
technique, viral DNA has been detected in cervical smears 
from women with no history of cervical lesions attending 
routine screening clinics and in substantial proportions of 
women with CIN or cervical carcinomas (17-20). PCR is 
known to be more sensitive than in situ hybridization, Southern 
blotting, or filter hybridization in the dectetion of HPV DNA 
(21,22). The PCR technique is thought to increase the 
sensitivity of HPV DNA screening tests and give a more 
accurate frequency of infections as well as better estimate of 
disease progression. · 
In the present study we evaluated the potential contribution 
of HPV analysis in the prediction of low-grade CIN progression, 
as well as the correlation between HPV detection and typing 
by PCR with cytological and histological diagnosis. 31 stained 
cytological specimens from PAP smears with a cytological 
and/or histological diagnosis of low grade squamous lesion 
(LGSL) were examined and 21 were found positive for HPV 
DNA. 
Materials and methods 
Patients and specimens. Specimens were obtained from 50 
women with cytological and/or histological evidence of low 
grade squamous lesions (LGSL: HPV and/or CIN I), treated 
at the Department of Cytology, 'Alexandra' Hospital, Athens, 
Greece. The cervical smears used were already fixed and 
stained to obtain the cytological diagnosis. 
The significant role of human papillomavirus (HPV) in cervical 
and anogenital neoplasia is well known (1-3). HPV types 16, 
18, 31, 33 and 35 have been detected in association with up 
to 80% of high grade lesions (CIN II and III) and with up to 
90% of invasive cervical cancers (4,5). These types are also 
found in low grade lesions (CIN I and wart virus change 
only) and even in women with negative cervical biopsies 
(6,7). The detection of these viral types in an individual 
patient might be predictive of the progression to a higher-
grade lesion (8,9). 
The management of patients with persistent borderline or 
wart virus change, or mild dyskaryosis is not clear as there is 
no cytopathological criterion to distinguish between patients 
who will have a low- or high-grade lesion on subsequent 
biopsy (10,11). Moreover, about 50% of lesions diagnosed as 
CIN I will regress spontaneously, and a too early intervention 
may result in the unnecessary treatment of women who are at 
little or no risk of developing carcinoma. There are however, 
patients with CIN I in whom the disease will persist or progress 
to carcinoma. HPV testing may usefully augment cytology by 
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DM4 extraction. For each case, one slide with stained cervical 
smear was used. The slides were soaked for 48 h in xylene 
followed by ethanol wash, to remove the coverslip. The cells 
were then scraped into a 1.5 ml Eppendorf, with the addition 
of 400 μΐ digestion buffer containing 100 mM NaCl, 10 mM 
Tris-HCl, 25 mM EDTA, 0.5% SDS pH 8.0 and lysed with 
the addition of 0.1 mg/ml proteinase Κ (Sigma, St. Louis, MO). 
Samples were incubated for 24 h at 37"C. Fresh proteinase Κ 
was added and the incubation was continued for another 24 h. 
The samples were then extracted once with phenol/chloroform 
and once with chloroform. DNA was precipitated with the 
addition of 20 μΐ 5 M NaCl and 1 ml ethanol, recovered with 
centrifugation at 13000 rpm for 15 min at 4°C, washed once 
with cold 70% ethanol and resuspended in 20 μΐ double 
distilled water. 
Oligonucleotide primers and PCR amplification. All specimens 
were examined for the presence of amplifiable DNA using a 
set of primers for a fragment of ß-globin gene (23). For the 
distinction of HPV types a multiplex PCR was employed, using 
simultaneously four pairs of primers (for HPV types 11, 16, 
18 and 33), with each virus type giving different length of 
amplified DNA (24). Two μΐ of the extracted DNA of each 
sample was amplified in a reaction solution of 50 μΐ containing 
20 mM (NH4)2S04, 2.5 mM MgCl2, 75 mM Tris-HCl pH 9.0, 
0.01% (w/v) Tween, 200 μΜ of each dNTP, 0.5 μΜ of each 
primer and 1.25 U Taq polymerase (Advanced Bio­
technologies). The mixture was heated for 1 min at 95"C, and 
then subjected to 35 cycles of amplification. 
ß-globin: Each cycle included a denaturation step at 94"C 
for 50 sec, an annealing step at 56UC for 40 sec and an 
elongation step at 72°C for 40 sec, increasing the elongation 
time 1 sec per cycle. 
HPV: Each cycle included a denaturation step at 94°C for 
50 sec, an annealing step at 56"C for 50 sec and an elongation 
step at 72°C for 50 sec, increasing the elongation time 1 sec 
per cycle. To establish type specificity of primer-directed 
amplification, each set of primers was tested with template 
Plasmid DNA of the five HPV types 6b, 11, 16, 18 and 33. 
PCR products were analyzed on a 2% agarose gel and photo-
graphed on a UV light transilluminator. 
Results 
The presence of amplifiable DNA, using primers for a fragment 
of ß-globin gene, was confirmed in 31 out of the 50 stained 
smears examined. The remaining 19 cytological preparations 
either contained only very small number of cells, too few to 
be successfully scraped off the slide, or chemicals used for the 
fixation and staining for cytology remained after extraction, 
inhibiting the PCR reaction. 
Detection and typing of HPV DNA was performed in the 
31 specimens with a cytological and/or histological diagnosis 
of low grade squamous lesion (LGSL). In 21 (68%) cases the 
presence of HPV DNA was confirmed, while 10 cases were 
found negative for HPV DNA. 
The typing of the virus revealed the higher prevalence of 
HPV 16, found in 11 cases (36%). HPV11 was found in 4 cases 
(13%), HPV18 in 3 cases (10%), HPV33 in 1 case (3.2%), 
while in 2 cases (6.5%) HPV 16 and HPV11 were simulta-
neously detected (Fig. 1). The primers used for the multiplex 





Figure 1. Detection and typing of HPV DNA using specific set of primers 
for each type in a multiplex PCR. The PCR products (315 bp for HPV-16. 
236 bp for HPV-11, 171 bp for HPV-33 and 143 bp for HPV-18) were 
electrophoresed on a 2% agarose gel. Lanes M: Weight molecular marker 
pUC18/HaeIII. lanes 1,5: samples positive for HPV-11; lanes 2,6: samples 
positive for HPV-18; lane 3: sample positive for HPV-16; lane 4: sample 
positive for HPV-33. 
PCR were within the E6 gene, providing amplification whether 
the HPV genome was episomal or integrated. Moreover, the 
length of the PCR products (315-143 bp) was relatively short 
and could be amplified from the very small yields of low-
molecular-weight DNA produced from such preparations. 
After 3 years of follow-up, persistence of the disease was 
found in 4 cases (13%) with high-risk HPV: 2 cases with 
HPV-16 (6.5%) and two cases (6.5%) with HPV-18. 
Progression of the disease was found in only one case with 
HPV-11 (3.2%), in which no histological diagnosis was 
available. In 26 cases (84%) (9 cases with HPV-16, 3 cases 
with HPV-11, 2 cases with both HPV-16 and HPV-11, one 
case with HPV-18, one case with HPV-33 and 10 cases with 
no detectable HPV DNA of the above types) with a negative 
cytological diagnosis, regression of the disease was detected 
(Table I, Fig. 2). 
Discussion 
It has been suggested that HPV testing may usefully augment 
cytology by helping to decide whether a patient with a mild 
abnormality needs immediate referral (25), while testing for 
high-risk HPV types appears to have more clinical utility 
(12). The sensitivity of the PCR method provides a more 
accurate frequency of infections. 
Formalin-fixed paraffin-embedded tissues, fresh tissues 
and exfoliated cervical cells recovered from cervical scrapes 
have been used for HPV DNA detection by PCR (26-28). 
However, fixed and stained cervical smears already used for 
cytology, which provide the possibility of retrospective studies 
with follow-up of the patients as well, have never been used. 
It is also possible to compare the results of the PCR analysis 
to cytology within the same sample, while confirmation as well 
as typing of the virus can provide further support for the 
treatment selection. Moreover, the ability to use archival 
cervical smears provides material for the investigation of 
cervical neoplasia and has important implications even in 
forensic medicine. The only disadvantage of this technique is 
that it obviously destroys the cytology specimen. 
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number. This rate of detection is in accordance with previous 
studies (30,31) detecting HPV DNA in 64%-75% of CIN I 
with cytological evidence of HPV infection, pointing to the 
questionable value of koilocytosis as specific marker of HPV 
infection, suggesting that HPV analysis is needed to prevent 
overclassification and overtreatment. Moreover, prevalence of 
high-risk HPV types (55%) found in this study has also been 
reported (25). 
The present study emphasizes the necessity of confirmation 
of HPV presence in cytological specimens by a more sensitive 
and specific molecular technique such as the PCR. The 
persistance or progression to high grade lesions in patients 
with mild cytological abnormalities can be predicted by 
molecular detection of HPV in some cases, particularly when 
combined with cytological analysis. However, the magnitude 
of this prediction is dependent on the population of patients 
studied and the clinical role of this approach therefore 
remains to be defined. 
We intend to extend this pilot study and continue long-term 
follow-up to evaluate whether this additional test can assist in 
predicting which women are at greater risk of eventually 
developing cervical cancer. 
Figure 2. Disease status according to the HPV type. (Observations after 3 years 
of follow-up). 
Due to the high sensitivity of the PCR technique, relatively 
low amounts of target DNA are required, which is important 
in the case of stained cytological material as used in this 
study. Moreover, the employment of the 'hot start' PCR 
technique provides more specific and efficient amplification 
from low target copy numbers (29). 
In the current study HPV detection was confirmed in 21 
out of the 31 cases (68%) examined with a cytological and/or 
histological diagnosis of HPV and/or CIN I. In ten cases 
HPV DNA was not detected, probably due to the presence of 
other type of HPV than 11, 16, 18 and 33, or to low viral copy 
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